Gland Pharma Limited
GLAND
Rangering i aksjer
#3228
Gland Pharma Limited, established in Hyderabad, India, in 1978, is a... Gland Pharma Limited, established in Hyderabad, India, in 1978, is a pharmaceutical company that specializes in the creation, production, and global distribution of generic injectable medications. Its product line features key active pharmaceutical ingredients such as heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, among others. The company's extensive therapeutic portfolio encompasses anti-infectives, anesthetics, anticoagulants, antimalarials, cardiovascular drugs, gastrointestinal treatments, pain management, hormones, fertility aids, anti-cancer agents, gynecological remedies, neurological and central nervous system medications, respiratory treatments, blood-related products, ophthalmological and otological solutions, orthopedics, hematinics, and various vitamins, minerals, and nutrients. Additionally, Gland Pharma provides contract development services. The company primarily operates on a business-to-business (B2B) model, distributing its products across major markets including the United States, Europe, Canada, Australia, India, and other international territories. Gland Pharma Limited functions as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
Aksjekurs
$33.33
Sist synkronisert: 2026-10-19
Markedsverdi
$5.50B
Endring (1 dag)
-0.68%
Endring (1 år)
52.16%
Land
IN
Handel Gland Pharma Limited (GLAND)
Kategori
Healthcare
EPS for Gland Pharma Limited (GLAND)
EPS per June 2026 TTM: $0.76
Ifølge de siste økonomiske rapportene og aksjekursen til Gland Pharma Limited er selskapets nåværende EPS (TTM) $0.76. Ved slutten av 2024 hadde selskapet en EPS på $0.56, en nedgang sammenlignet med EPS-en i 2023 som var $0.58.
EPS-historikk for Gland Pharma Limited fra 2017 til 2026
EPS ved slutten av hvert år
| År | EPS | Endre |
|---|---|---|
| 2026 (TTM) | $0.76 | 51.22% |
| 2025 | $0.50 | -11.86% |
| 2024 | $0.56 | -2.56% |
| 2023 | $0.58 | -40.63% |
| 2022 | $0.97 | 12.85% |
| 2021 | $0.86 | 30.13% |
| 2020 | $0.66 | 57.68% |
| 2019 | $0.42 | 31.96% |
| 2018 | $0.32 | -22.71% |
| 2017 | $0.41 | 0.00% |
EPS for lignende selskaper eller konkurrenter
| Selskap | EPS | EPS-forskjell | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -26.43% |
IN
|
